Insights
Notes from the desk.
Long-form writing from Nucleus partners. Fundraise mechanics, term sheets, M&A, valuations, risk and tax. Filter by service line, tag, or author; sort newest or oldest; or search the archive.
Latest: 26 May 2026
Founder vesting: why VCs ask for re-vesting at Series A, and how to negotiate
You started the company four years ago. The investor is offering a Series A term sheet that requires you to put your already-earned shares back on a four-year vesting schedule. Why this happens, and what good negotiation actually looks like.
Pro-rata rights at Series B: what they actually mean when the round opens
The Series A investor signed a pro-rata clause two years ago. The Series B lead wants the full round. Whose right wins, and what the founder should actually push for, depends on details most founders never read.
Bridge rounds: the convertible that saves you, or signals you ran out of runway
A bridge done right gives you the eight months you needed to hit the metric that prices the next round. A bridge done wrong tells every investor in town the previous round was mis-sized. The difference is in how it gets structured, not in how much it raises.
Pre-money vs post-money: the 2-3% equity that quietly costs founders the round
Founders agree to a pre-money number, sign a term sheet, and discover at closing that the ESOP top-up was carved out of their slice — not the round. Two or three percentage points later, the lesson is expensive.
SAFE vs CCPS in Indian early-stage rounds: which one actually fits
Founders ask for SAFEs because they read about them. Indian counsel quietly redrafts them as CCPS because FEMA and the Companies Act leave no other option. The mechanics matter — and so does the cap-table outcome.
The case for hiring an outside banker — even when you have a great cap table
Founders with strong investor networks ask why they should pay a banker at all. The honest answer is not about access. It is about leverage and time.
ESOP economics for founders: when to top up, how to model the dilution
ESOP is the most consequential cap-table line item that founders pay the least attention to. The top-up math at each round is where founders give away half a point at a time without noticing.
Strategic exit vs. PE buyout: which conversation are you actually in?
They look similar from the founder side. They are not. The buyer cares about different things, pays in different shapes, and the post-deal life looks different.
Fundraise readiness audit: nine things a partner-led review actually finds
Most founders think they are ready six weeks before they are. A formal audit gives you a punch-list and a realistic timeline.
The 14-day pitch-to-term-sheet myth: what actually goes into a fast close
Fast closes happen. They are not magic. The work that makes them possible happens in the eight weeks before the first pitch, not the two weeks after.
Anti-dilution clauses explained: weighted-average vs full-ratchet, and why it matters
Anti-dilution is an asymmetric clause. It only triggers in a down round. That's exactly why founders should care about it before the round closes.
Term sheet line-by-line: liquidation preference, anti-dilution, drag-along, tag-along
A term sheet is two pages. Two of those pages decide who gets what when the company is sold. Read them like that, not like a price quote.
Cap-table hygiene: the six mistakes we see in first-time founder docs
A messy cap-table does not kill a round. It slows it. Cleanup costs you four weeks of diligence-driven discovery you could have avoided in two days.
How investors really read your information memorandum — and what they skip
The deck gets you the meeting. The IM is read by analysts on a Saturday morning with a checklist. Most founders write IMs as if they will be read like a deck. They are not.
The math of dilution: what a $5M raise actually costs you over 18 months
Round size is the headline number. The cost is what your slice looks like after the next two rounds, an ESOP top-up, and a liquidation preference you forgot to read.